Filing Flows › Comparisons › MIST vs MNOV
Milestone Pharmaceuticals vs Medicinova: MIST and MNOV compared
Milestone Pharmaceuticals is the larger company: $559K of revenue in its latest quarter (Q2 2026) against $458K for Medicinova (Q2 2026).
Where the money goes: MIST and MNOV
Milestone Pharmaceuticals (MIST) · Q2 2026
Milestone Pharmaceuticals, Q2 2026: revenue $559K, net loss $28.6M, operating cash flow −$22.7M. The chart follows the revenue to costs, profit and cash.
Medicinova (MNOV) · Q2 2026
Medicinova, Q2 2026: revenue $458K (+241% year over year), operating margin -554.3%, net loss $2.3M, operating cash flow −$1.9M. The chart follows the revenue to costs, profit and cash.
| Milestone Pharmaceuticals (MIST) | Medicinova (MNOV) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $559K | $458K |
| Revenue growth, Y/Y | — | +241% |
| Operating margin | n/m | -554.3% |
| Net earnings | −$28.6M | −$2.3M |
| Net margin | — | -504.8% |
| Operating cash flow | −$22.7M | −$1.9M |
Questions
Which is bigger, Milestone Pharmaceuticals or Medicinova?
Milestone Pharmaceuticals is the larger company: $559K of revenue in its latest quarter (Q2 2026) against $458K for Medicinova (Q2 2026).
More: Milestone Pharmaceuticals earnings · how Milestone Pharmaceuticals makes money · Medicinova earnings · how Medicinova makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 12, 2026; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.